Profiles

Keywords
Last Name
Institution

Annabelle Volgman

Concepts (330)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
22
2022
197
8.480
Why?
Cardiovascular Diseases
16
2021
410
4.290
Why?
Stroke
19
2022
367
4.090
Why?
Anticoagulants
6
2022
151
2.150
Why?
Heart Failure
7
2022
232
2.060
Why?
Healthcare Disparities
6
2020
82
2.030
Why?
Coronary Artery Disease
8
2022
159
2.020
Why?
Female
68
2022
18253
1.850
Why?
Sex Factors
17
2021
542
1.840
Why?
Humans
86
2022
31481
1.730
Why?
Myocardial Infarction
9
2022
187
1.670
Why?
Exercise
7
2022
454
1.630
Why?
Risk Factors
28
2022
2664
1.570
Why?
Risk Assessment
14
2022
806
1.520
Why?
Hospital Mortality
6
2021
192
1.470
Why?
Hospitalization
8
2021
359
1.450
Why?
Life Style
8
2020
219
1.440
Why?
Women's Health
4
2020
228
1.430
Why?
Primary Prevention
4
2022
53
1.370
Why?
Cardiology
4
2021
102
1.370
Why?
Physicians, Women
3
2022
15
1.320
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
81
1.270
Why?
Sex Characteristics
5
2021
128
1.240
Why?
Aged
38
2022
10295
1.240
Why?
Myocardial Ischemia
3
2021
63
1.230
Why?
Catheter Ablation
3
2022
76
1.220
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
31
1.160
Why?
Adrenergic beta-Antagonists
2
2020
45
1.160
Why?
Health Status Disparities
4
2019
70
1.150
Why?
Arrhythmias, Cardiac
6
2019
158
1.120
Why?
Defibrillators, Implantable
3
2021
31
1.100
Why?
Anti-Arrhythmia Agents
7
2022
101
1.060
Why?
Male
41
2022
17583
1.040
Why?
American Heart Association
3
2021
39
0.980
Why?
United States
23
2021
2539
0.980
Why?
Echocardiography, Doppler, Color
2
2019
15
0.970
Why?
Middle Aged
30
2021
11209
0.920
Why?
Coronavirus
1
2021
2
0.900
Why?
Pregnancy Complications, Cardiovascular
5
2021
16
0.890
Why?
Electrocardiography
7
2015
209
0.880
Why?
Breast Neoplasms
3
2021
442
0.860
Why?
Length of Stay
4
2020
377
0.840
Why?
Chest Pain
1
2020
23
0.830
Why?
Endothelium
1
2020
15
0.830
Why?
Social Media
1
2021
35
0.820
Why?
Quality of Life
5
2021
663
0.810
Why?
Patient Care Management
2
2021
18
0.800
Why?
Brain Ischemia
1
2021
122
0.790
Why?
Vascular Diseases
1
2020
59
0.790
Why?
Takotsubo Cardiomyopathy
1
2019
20
0.780
Why?
Myxoma
1
2019
7
0.780
Why?
Cardiomyopathies
1
2019
39
0.770
Why?
Heart Neoplasms
1
2019
21
0.770
Why?
Heart Failure, Diastolic
1
2018
2
0.760
Why?
Women's Health Services
1
2018
12
0.750
Why?
Comorbidity
5
2021
562
0.740
Why?
Culturally Competent Care
1
2018
10
0.730
Why?
Heart Diseases
1
2020
102
0.730
Why?
Age Factors
8
2021
943
0.720
Why?
Delivery of Health Care, Integrated
1
2018
30
0.720
Why?
Prevalence
6
2020
544
0.720
Why?
Ambulatory Care Facilities
1
2018
42
0.720
Why?
Emigrants and Immigrants
1
2018
25
0.710
Why?
Warfarin
3
2016
60
0.700
Why?
Coronavirus Infections
1
2020
97
0.700
Why?
Heart Ventricles
1
2019
218
0.700
Why?
Pneumonia, Viral
1
2020
102
0.700
Why?
Atherosclerosis
1
2018
57
0.690
Why?
Antineoplastic Agents
1
2020
274
0.660
Why?
Lipoprotein(a)
1
2016
10
0.620
Why?
Dyslipidemias
1
2016
26
0.610
Why?
Cognition
3
2020
1206
0.610
Why?
Electrodes
1
2015
16
0.590
Why?
Prognosis
7
2021
1028
0.590
Why?
Diabetes Mellitus
3
2022
150
0.590
Why?
Treatment Outcome
12
2022
3910
0.580
Why?
Secondary Prevention
3
2022
67
0.570
Why?
Cost of Illness
1
2015
65
0.570
Why?
Social Support
1
2016
224
0.540
Why?
Electric Countershock
6
2020
21
0.530
Why?
Patient Readmission
3
2019
129
0.520
Why?
Aspirin
2
2020
90
0.520
Why?
Hypertension
6
2022
283
0.520
Why?
Health Knowledge, Attitudes, Practice
1
2016
230
0.520
Why?
Magnetic Resonance Imaging
1
2019
1273
0.510
Why?
Aged, 80 and over
9
2021
5234
0.490
Why?
Pregnancy
7
2021
457
0.460
Why?
Adult
14
2022
9779
0.460
Why?
Patient Acceptance of Health Care
1
2012
85
0.450
Why?
Coronary Angiography
3
2020
106
0.450
Why?
Cardiovascular System
2
2021
10
0.430
Why?
Acute Kidney Injury
2
2021
64
0.410
Why?
Cardiac Resynchronization Therapy Devices
2
2019
10
0.400
Why?
Cardiovascular Agents
2
2021
34
0.400
Why?
Aortic Valve Stenosis
2
2020
28
0.400
Why?
Transcatheter Aortic Valve Replacement
2
2020
28
0.400
Why?
Hospital Costs
2
2020
73
0.390
Why?
Feasibility Studies
2
2020
281
0.380
Why?
Practice Guidelines as Topic
3
2021
389
0.350
Why?
Ventricular Fibrillation
2
2021
27
0.340
Why?
Heart Atria
2
2019
89
0.340
Why?
Retrospective Studies
8
2021
3591
0.330
Why?
Administration, Oral
3
2016
164
0.300
Why?
Health Status
2
2018
249
0.290
Why?
Sex Distribution
3
2019
89
0.290
Why?
Randomized Controlled Trials as Topic
5
2020
375
0.290
Why?
Antihypertensive Agents
2
2020
91
0.280
Why?
Hemorrhage
5
2020
90
0.280
Why?
Risk Adjustment
2
2021
14
0.280
Why?
Hospital Charges
2
2020
23
0.270
Why?
African Americans
3
2016
818
0.260
Why?
Incidence
4
2020
829
0.260
Why?
Logistic Models
3
2021
479
0.260
Why?
Illinois
2
2021
266
0.260
Why?
Obesity
4
2020
338
0.260
Why?
Aortic Valve
2
2020
35
0.260
Why?
Cardiotoxicity
2
2020
9
0.260
Why?
Leadership
2
2022
109
0.260
Why?
Age Distribution
2
2020
110
0.250
Why?
Cost-Benefit Analysis
2
2022
153
0.250
Why?
Morbidity
2
2019
71
0.250
Why?
Young Adult
3
2020
2277
0.240
Why?
Health Promotion
2
2016
186
0.240
Why?
Polypharmacy
1
2022
9
0.240
Why?
Vitamin K
1
2022
11
0.240
Why?
Sotalol
1
2021
10
0.230
Why?
Cardiac Electrophysiology
1
2021
3
0.230
Why?
Coronary Circulation
2
2020
49
0.230
Why?
Troponin
1
2021
11
0.230
Why?
Shock, Cardiogenic
1
2021
10
0.230
Why?
Diagnostic Techniques, Cardiovascular
1
2021
3
0.230
Why?
Sexism
1
2021
8
0.230
Why?
Water-Electrolyte Imbalance
1
2021
3
0.220
Why?
Hormones
1
2021
19
0.220
Why?
Societies, Medical
2
2020
209
0.220
Why?
Atrial Appendage
1
2022
47
0.220
Why?
Death, Sudden, Cardiac
1
2021
30
0.220
Why?
Women's Rights
1
2021
3
0.220
Why?
Overweight
1
2022
67
0.220
Why?
Adolescent
2
2020
2667
0.220
Why?
National Institutes of Health (U.S.)
1
2021
33
0.220
Why?
Pacemaker, Artificial
2
2019
32
0.220
Why?
Alcohol Drinking
1
2022
86
0.220
Why?
Weight Loss
1
2022
114
0.220
Why?
Angioplasty
1
2020
17
0.220
Why?
Signal Processing, Computer-Assisted
2
1998
44
0.220
Why?
Sleep Apnea, Obstructive
1
2022
72
0.220
Why?
Health Expenditures
1
2020
20
0.220
Why?
Hyperlipidemias
1
2020
29
0.210
Why?
Career Choice
1
2021
33
0.210
Why?
Physician-Patient Relations
1
2021
47
0.210
Why?
Heart Valve Diseases
1
2020
32
0.210
Why?
Cross-Sectional Studies
4
2017
986
0.210
Why?
Peripheral Arterial Disease
1
2020
21
0.210
Why?
Disease Outbreaks
1
2021
87
0.210
Why?
Postoperative Hemorrhage
1
2020
31
0.210
Why?
Periodicals as Topic
1
2021
46
0.210
Why?
Myocardial Revascularization
1
2020
25
0.210
Why?
Postnatal Care
1
2020
9
0.210
Why?
Delivery, Obstetric
1
2020
15
0.210
Why?
Accidental Falls
1
2022
118
0.210
Why?
Radiation-Protective Agents
1
2020
4
0.210
Why?
Colchicine
1
2020
9
0.210
Why?
Protective Factors
1
2020
19
0.210
Why?
Social Class
1
2020
71
0.200
Why?
After-Hours Care
1
2019
1
0.200
Why?
Endovascular Procedures
1
2020
79
0.200
Why?
Income
1
2020
77
0.200
Why?
Prostatic Neoplasms
1
2021
122
0.200
Why?
Heart Valve Prosthesis Implantation
1
2020
49
0.200
Why?
Odds Ratio
2
2020
327
0.200
Why?
Global Health
1
2019
60
0.200
Why?
Radiation Injuries
1
2020
44
0.200
Why?
Thrombolytic Therapy
1
2020
85
0.200
Why?
Cardiac Resynchronization Therapy
1
2019
23
0.190
Why?
Multimodal Imaging
1
2019
30
0.190
Why?
Up-Regulation
2
2021
220
0.190
Why?
Health Behavior
1
2020
177
0.190
Why?
Clinical Trials as Topic
1
2021
378
0.190
Why?
Treatment Refusal
1
2018
13
0.190
Why?
Heart
1
2019
110
0.190
Why?
Asia, Western
1
2018
2
0.180
Why?
Indian Ocean Islands
1
2018
2
0.180
Why?
Procainamide
1
1998
20
0.180
Why?
Heart Transplantation
1
1998
50
0.180
Why?
Atrial Flutter
1
1998
13
0.180
Why?
Graft Rejection
1
1998
84
0.180
Why?
Tachycardia
2
2021
43
0.180
Why?
Intensive Care Units
1
2021
316
0.180
Why?
Walking
1
2020
249
0.180
Why?
Sulfonamides
1
1998
64
0.180
Why?
Pandemics
1
2020
203
0.180
Why?
Reproducibility of Results
3
2017
886
0.170
Why?
Memory Disorders
1
2019
181
0.170
Why?
Diagnosis, Differential
1
2019
467
0.170
Why?
Inpatients
1
2019
154
0.170
Why?
Coronary Disease
2
2020
98
0.170
Why?
Lupus Erythematosus, Systemic
1
2020
193
0.170
Why?
Diet Surveys
1
2017
26
0.170
Why?
Pyridones
1
2016
19
0.160
Why?
Nutrition Assessment
1
2017
53
0.160
Why?
Patient Discharge
1
2018
163
0.160
Why?
Thiazoles
1
2016
38
0.160
Why?
Evidence-Based Practice
1
2017
86
0.160
Why?
Pyridines
1
2016
50
0.160
Why?
Evidence-Based Medicine
1
2018
239
0.160
Why?
Neoplasms
1
2020
280
0.160
Why?
Coronary Vessels
2
2021
52
0.160
Why?
Georgia
1
2016
16
0.160
Why?
Patient Selection
2
2020
264
0.160
Why?
Diet, Mediterranean
1
2017
57
0.160
Why?
Cholesterol, LDL
1
2016
46
0.150
Why?
Sensitivity and Specificity
2
2015
580
0.150
Why?
Platelet Aggregation Inhibitors
1
2016
62
0.150
Why?
Dementia
1
2022
545
0.150
Why?
Pyrazoles
1
2016
55
0.150
Why?
Health Surveys
1
2016
102
0.150
Why?
Self Efficacy
1
2016
65
0.150
Why?
Miniaturization
1
2015
3
0.150
Why?
Preventive Health Services
1
2015
16
0.150
Why?
Equipment Design
2
2015
198
0.150
Why?
Asian Americans
1
2015
53
0.140
Why?
Chicago
2
2016
955
0.140
Why?
Equipment Failure Analysis
1
2015
116
0.140
Why?
Heart Rate
2
2009
161
0.140
Why?
Smoking
2
2018
202
0.130
Why?
Needs Assessment
1
2013
50
0.130
Why?
Cardiac Pacing, Artificial
2
1992
63
0.120
Why?
Drug Monitoring
1
2012
29
0.120
Why?
Heart Conduction System
1
1992
29
0.120
Why?
Activities of Daily Living
1
2016
495
0.120
Why?
Data Collection
1
2012
120
0.120
Why?
Cohort Studies
3
2022
2014
0.100
Why?
Echocardiography
3
2019
197
0.100
Why?
Percutaneous Coronary Intervention
2
2020
25
0.100
Why?
Motor Activity
1
2013
397
0.100
Why?
Coronary Artery Bypass
2
2020
75
0.100
Why?
Survival Rate
2
2019
465
0.090
Why?
Databases, Factual
2
2019
391
0.080
Why?
Azetidines
1
2006
4
0.080
Why?
Benzylamines
1
2006
15
0.080
Why?
Body Mass Index
2
2020
458
0.070
Why?
Severity of Illness Index
2
2021
1240
0.070
Why?
Time Factors
3
2021
1902
0.070
Why?
Endpoint Determination
1
2004
31
0.070
Why?
Postoperative Complications
2
2020
1083
0.060
Why?
Registries
2
2022
214
0.060
Why?
Follow-Up Studies
2
2019
2028
0.060
Why?
Flecainide
1
2021
13
0.060
Why?
Microcirculation
1
2021
40
0.060
Why?
Double-Blind Method
2
2006
559
0.060
Why?
Ischemia
1
2021
35
0.060
Why?
Prospective Studies
2
1998
1934
0.060
Why?
Peripartum Period
1
2021
3
0.060
Why?
Pregnancy, High-Risk
1
2021
3
0.060
Why?
Chlorides
1
2021
27
0.060
Why?
Diuretics
1
2021
16
0.060
Why?
Recurrence
2
2006
389
0.050
Why?
Health Services Research
1
2021
45
0.050
Why?
Sodium
1
2021
81
0.050
Why?
Education, Medical
1
2021
45
0.050
Why?
Amputation
1
2020
20
0.050
Why?
Vascular Endothelial Growth Factor A
1
2020
70
0.050
Why?
Patient Preference
1
2021
36
0.050
Why?
Abortion, Spontaneous
1
2020
9
0.050
Why?
Fetal Growth Retardation
1
2020
4
0.050
Why?
Polycystic Ovary Syndrome
1
2020
5
0.050
Why?
Hypercholesterolemia
1
2020
39
0.050
Why?
Menopause, Premature
1
2020
7
0.050
Why?
Ischemic Attack, Transient
1
2020
27
0.050
Why?
Sleep Apnea, Central
1
2000
26
0.050
Why?
Lactation
1
2021
77
0.050
Why?
Health Care Costs
1
2020
81
0.050
Why?
Case-Control Studies
2
2000
687
0.050
Why?
Radiotherapy
1
2020
65
0.050
Why?
Attitude to Health
1
2020
117
0.050
Why?
Curriculum
1
2021
158
0.050
Why?
Costs and Cost Analysis
1
2019
39
0.050
Why?
Autoimmune Diseases
1
2020
66
0.050
Why?
Cause of Death
1
2019
78
0.050
Why?
Thrombectomy
1
2019
51
0.050
Why?
Multivariate Analysis
1
2020
390
0.050
Why?
Disease Management
1
2020
147
0.050
Why?
Psychology
1
2018
24
0.050
Why?
Health Services Needs and Demand
1
2018
71
0.050
Why?
Heredity
1
2018
8
0.050
Why?
Blood Pressure
1
2020
260
0.050
Why?
Diet, Western
1
2017
8
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
224
0.040
Why?
Quality Improvement
1
2018
173
0.040
Why?
Breast Feeding
1
2018
177
0.040
Why?
Waist Circumference
1
2015
34
0.040
Why?
Risk
1
2016
228
0.040
Why?
Decision Making
1
2018
232
0.040
Why?
Drug Therapy, Combination
1
2016
265
0.040
Why?
Body Composition
1
2016
81
0.040
Why?
Body Weight
1
2016
167
0.040
Why?
Genetic Predisposition to Disease
1
2018
462
0.040
Why?
Patient Compliance
1
2016
200
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
2
0.030
Why?
Dextroamphetamine
1
1993
6
0.030
Why?
Social Networking
1
2013
10
0.030
Why?
Syncope
1
1993
9
0.030
Why?
Hypotension, Orthostatic
1
1993
17
0.030
Why?
Efficiency
1
2013
21
0.030
Why?
Albuterol
1
1993
17
0.030
Why?
Bradycardia
1
1993
29
0.030
Why?
Interviews as Topic
1
2013
152
0.030
Why?
Program Evaluation
1
2013
153
0.030
Why?
Tachycardia, Ventricular
1
1992
35
0.030
Why?
Cardiac Catheterization
1
1992
110
0.030
Why?
Asthma
1
1993
182
0.030
Why?
Animals
1
2020
5312
0.020
Why?
Estrogen Replacement Therapy
1
2006
22
0.020
Why?
Thromboembolism
1
2006
37
0.020
Why?
Chi-Square Distribution
1
2006
178
0.020
Why?
Proportional Hazards Models
1
2006
390
0.020
Why?
Combined Modality Therapy
1
2004
456
0.020
Why?
Electrocardiography, Ambulatory
1
2000
18
0.010
Why?
Bronchoscopy
1
2000
38
0.010
Why?
Respiration
1
2000
37
0.010
Why?
Anesthesia
1
2000
29
0.010
Why?
Tracheostomy
1
2000
28
0.010
Why?
Child
1
2000
1572
0.010
Why?
False Positive Reactions
1
1993
40
0.010
Why?
Administration, Inhalation
1
1993
37
0.010
Why?
Posture
1
1993
92
0.010
Why?
Action Potentials
1
1993
143
0.010
Why?
ROC Curve
1
1992
153
0.010
Why?
Analysis of Variance
1
1992
364
0.010
Why?
Volgman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description